Therefore, resveratrol’s ability to inhibit JAK2 and STAT3 signaling pathways positions it as a potential therapeutic agent in gliomas, leading to reduced tumor growth and increased apoptosis. This evidence concerns the gene JAK2 and central nervous system cancer.